| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > Sales Management and CRM - Digging Into the Memory |
|
Useful Advices - Sales Management and CRM - Digging Into the Memory
...An important step in organizing CRM based sales management was to build up or gather this (central) memory According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product so everybody could use it… The memory started to be an issue. From every part of the organization, differe ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nt client addresses and different product history -- some clients bought product X with one sales unit and produ lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ct Y at another office –- were gathered. The problem of distributed client data became visible when CRM starte here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe d to be a topic. In order to manage relations, you first need to figure out the history of the client relations. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro Do we know this client, what has he or she bought, and most of all – mining in the data -- what is the client b ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ehavior? Does this client belong to a certain group and can we benefit from knowing this?
So, one of the chall easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi enges of CRM was thus to bring forward an overview of a client, gathering the different transactions made in dif nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ferent product systems. Now that you have this central memory, you can analyze client behavior. What do they bu and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y and when, what are cross-selling opportunities and most of all, are there groups of clients to establish? And ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi how does the individual client within a group buys. In investment management you have different profiles. Some ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a private investor will trade on a monthly bases, others trade actively and again some other group will follow the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod advice of a guru. The trade frequency various over the different groups. CRM is more than sales management abo cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ut offering different approaches just because you have learned –- from your client history –- that different cli tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ents have different preferences.
Where sales management is about having one product and searching for clients t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel o buy it, CRM is about having client groups and behavior and adapt your offerings in a way that it best fits the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust se needs Having an available client history is one requirement. The rest is just digging into this collective m y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products emory and understand what profitable client groups are. These new knowledge or requirements should be channeled . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de to the sales agents in the front-office. If they are no longer to be sold product only, they should receive tip elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s and leads. And with this a new client history will be made. Refreshing the (central) memory. © 2006 Hans Bool tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Secretes of Dealing with Recruitment Agencies Steel Buildings – Making the Right Decision
|